Evidence map›Paper›PMID 10631140›Full record

ArticleAmerican journal of human genetics2000

NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes.

P Riva, L Corrado, F Natacci, P Castorina, B L Wu, G H Schneider, M Clementi, R Tenconi, B R Korf, L Larizza

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. BiallelicGenes · 2022
    Article
  3. Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor.Laboratory investigation; a journal of technical methods and pathology · 2022
    Article
  4. Article
  5. Article
  6. AtypicalGenes · 2021
    Review
  7. Article
  8. Article
  9. Clinical characterization of children and adolescents with NF1 microdeletions.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2020
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. A highly sensitive genetic protocol to detect NF1 mutations.The Journal of molecular diagnostics : JMD · 2011
    Article
  18. Review
  19. Article
  20. Copy number variations and cancer.Genome medicine · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

P RivaDepartment of Biology and Genetics, Medical Faculty, University of Milan, 20133 Milan, Italy.
L Corrado
F Natacci
P Castorina
B L Wu
G H Schneider
M Clementi
R Tenconi
B R Korf
L Larizza
University of Milan · ITBoston Children's Hospital · USUniversity of Padua · ITHarvard University · US

Funding

Telethon E.0780
6 · The paper itself

Abstract

Two familial and seven sporadic patients with neurofibromatosis 1-who showed dysmorphism, learning disabilities/mental retardation, and additional signs and carried deletions of the NF1 gene-were investigated by use of a two-step FISH approach to characterize the deletions. With FISH of YAC clones belonging to a 7-Mb 17q11.2 contig, we estimated the extension of all of the deletions and identified the genomic regions harboring the breakpoints. Mosaicism accounted for the mild phenotype in two patients. In subsequent FISH experiments, performed with locus-specific probes generated from the same YACs by means of a novel procedure, we identified the smallest region of overlapping (SRO), mapped the deletion breakpoints, and identified the genes that map to each deletion interval. From centromere to telomere, the approximately 0.8-Mb SRO includes sequence-tagged site 64381, the SUPT6H gene (encoding a transcription factor involved in chromatin structure), and NF1. Extending telomerically from the SRO, two additional genes-BLMH, encoding a hydrolase involved in bleomycin resistance, and ACCN1, encoding an amiloride-sensitive cation channel expressed in the CNS-were located in the deleted intervals of seven and three patients, respectively. An apparently common centromeric deletion breakpoint was shared by all of the patients, whereas a different telomeric breakpoint defined a deletion interval of 0.8-3 Mb. There was no apparent correlation between the extent of the deletion and the phenotype. This characterization of gross NF1 deletions provides the premise for addressing correctly any genotype-phenotype correlation in the subset of patients with NF1 deletions.

Indexed as

Chromosome DeletionChromosome MappingChromosomes, Artificial, YeastFemaleGenes, Neurofibromatosis 1HumansIn Situ Hybridization, FluorescenceMaleNeurofibromatosis 1Oligonucleotide ProbesSyndromeOligonucleotide Probes

Identifiers

PMID10631140
PMCPMC1288315
OpenAlexW2091409931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.